Cargando…

An analysis of abnormalities in the B cell receptor repertoire in patients with systemic sclerosis using high-throughput sequencing

Systemic sclerosis is a chronic multisystem autoimmune disease that is associated with polyclonal B cell hyperreactivity. The CDR3 of BCRs is the major site of antigen recognition. Therefore, we analyzed the BCR repertoire of patients with SSc. The BCR repertoires in 12 subjects including eight SSc...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Xiaodong, Shao, Tihong, Huo, Feifei, Zheng, Chenqing, Li, Wanyu, Jiang, Zhenyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PeerJ Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6968515/
https://www.ncbi.nlm.nih.gov/pubmed/31988805
http://dx.doi.org/10.7717/peerj.8370
_version_ 1783489149381115904
author Shi, Xiaodong
Shao, Tihong
Huo, Feifei
Zheng, Chenqing
Li, Wanyu
Jiang, Zhenyu
author_facet Shi, Xiaodong
Shao, Tihong
Huo, Feifei
Zheng, Chenqing
Li, Wanyu
Jiang, Zhenyu
author_sort Shi, Xiaodong
collection PubMed
description Systemic sclerosis is a chronic multisystem autoimmune disease that is associated with polyclonal B cell hyperreactivity. The CDR3 of BCRs is the major site of antigen recognition. Therefore, we analyzed the BCR repertoire of patients with SSc. The BCR repertoires in 12 subjects including eight SSc patients and four healthy controls were characterized by high-throughput sequencing, and bioinformatics analysis were studied. The average CDR3 length in the SSc group was significantly shorter. The SSc patient displayed more diverse BCR. Moreover, SSc patients with mild skin sclerosis, anti-Scl70, interstitial lung disease or female sex were more diversified. B cells from the SSc patients showed a differential V and J gene usage. SSc patients had distinct BCR repertoires.These findings reflected the differences of BCR repertoires between SSc patients and controls. The higher-usage genes for the BCR sequence might be potential biomarkers of B cell-targeted therapies or diagnosis for SSc.
format Online
Article
Text
id pubmed-6968515
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher PeerJ Inc.
record_format MEDLINE/PubMed
spelling pubmed-69685152020-01-27 An analysis of abnormalities in the B cell receptor repertoire in patients with systemic sclerosis using high-throughput sequencing Shi, Xiaodong Shao, Tihong Huo, Feifei Zheng, Chenqing Li, Wanyu Jiang, Zhenyu PeerJ Immunology Systemic sclerosis is a chronic multisystem autoimmune disease that is associated with polyclonal B cell hyperreactivity. The CDR3 of BCRs is the major site of antigen recognition. Therefore, we analyzed the BCR repertoire of patients with SSc. The BCR repertoires in 12 subjects including eight SSc patients and four healthy controls were characterized by high-throughput sequencing, and bioinformatics analysis were studied. The average CDR3 length in the SSc group was significantly shorter. The SSc patient displayed more diverse BCR. Moreover, SSc patients with mild skin sclerosis, anti-Scl70, interstitial lung disease or female sex were more diversified. B cells from the SSc patients showed a differential V and J gene usage. SSc patients had distinct BCR repertoires.These findings reflected the differences of BCR repertoires between SSc patients and controls. The higher-usage genes for the BCR sequence might be potential biomarkers of B cell-targeted therapies or diagnosis for SSc. PeerJ Inc. 2020-01-14 /pmc/articles/PMC6968515/ /pubmed/31988805 http://dx.doi.org/10.7717/peerj.8370 Text en ©2020 Shi et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, reproduction and adaptation in any medium and for any purpose provided that it is properly attributed. For attribution, the original author(s), title, publication source (PeerJ) and either DOI or URL of the article must be cited.
spellingShingle Immunology
Shi, Xiaodong
Shao, Tihong
Huo, Feifei
Zheng, Chenqing
Li, Wanyu
Jiang, Zhenyu
An analysis of abnormalities in the B cell receptor repertoire in patients with systemic sclerosis using high-throughput sequencing
title An analysis of abnormalities in the B cell receptor repertoire in patients with systemic sclerosis using high-throughput sequencing
title_full An analysis of abnormalities in the B cell receptor repertoire in patients with systemic sclerosis using high-throughput sequencing
title_fullStr An analysis of abnormalities in the B cell receptor repertoire in patients with systemic sclerosis using high-throughput sequencing
title_full_unstemmed An analysis of abnormalities in the B cell receptor repertoire in patients with systemic sclerosis using high-throughput sequencing
title_short An analysis of abnormalities in the B cell receptor repertoire in patients with systemic sclerosis using high-throughput sequencing
title_sort analysis of abnormalities in the b cell receptor repertoire in patients with systemic sclerosis using high-throughput sequencing
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6968515/
https://www.ncbi.nlm.nih.gov/pubmed/31988805
http://dx.doi.org/10.7717/peerj.8370
work_keys_str_mv AT shixiaodong ananalysisofabnormalitiesinthebcellreceptorrepertoireinpatientswithsystemicsclerosisusinghighthroughputsequencing
AT shaotihong ananalysisofabnormalitiesinthebcellreceptorrepertoireinpatientswithsystemicsclerosisusinghighthroughputsequencing
AT huofeifei ananalysisofabnormalitiesinthebcellreceptorrepertoireinpatientswithsystemicsclerosisusinghighthroughputsequencing
AT zhengchenqing ananalysisofabnormalitiesinthebcellreceptorrepertoireinpatientswithsystemicsclerosisusinghighthroughputsequencing
AT liwanyu ananalysisofabnormalitiesinthebcellreceptorrepertoireinpatientswithsystemicsclerosisusinghighthroughputsequencing
AT jiangzhenyu ananalysisofabnormalitiesinthebcellreceptorrepertoireinpatientswithsystemicsclerosisusinghighthroughputsequencing
AT shixiaodong analysisofabnormalitiesinthebcellreceptorrepertoireinpatientswithsystemicsclerosisusinghighthroughputsequencing
AT shaotihong analysisofabnormalitiesinthebcellreceptorrepertoireinpatientswithsystemicsclerosisusinghighthroughputsequencing
AT huofeifei analysisofabnormalitiesinthebcellreceptorrepertoireinpatientswithsystemicsclerosisusinghighthroughputsequencing
AT zhengchenqing analysisofabnormalitiesinthebcellreceptorrepertoireinpatientswithsystemicsclerosisusinghighthroughputsequencing
AT liwanyu analysisofabnormalitiesinthebcellreceptorrepertoireinpatientswithsystemicsclerosisusinghighthroughputsequencing
AT jiangzhenyu analysisofabnormalitiesinthebcellreceptorrepertoireinpatientswithsystemicsclerosisusinghighthroughputsequencing